Line Borgwardt Selected Research

Line Borgwardt Research Topics

6	alpha-Mannosidosis 06/2020 - 09/2014
3	Neurologic Manifestations (Neurological Manifestations) 06/2020 - 01/2018
1	Disease Progression 05/2024
1	Weight Loss (Weight Reduction) 06/2022
1	Thyroiditis 06/2022
1	type 1 familial Hypocalciuric hypercalcemia 09/2021
1	Adenoma (Adenomas) 09/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 09/2021
1	Parathyroid Neoplasms (Parathyroid Neoplasm) 09/2021
1	Multiple Endocrine Neoplasia Type 2a (MEN 2) 01/2021
1	Neoplasms (Cancer) 01/2021
1	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 12/2020
1	Paraganglioma (Paragangliomas) 08/2020
1	Fibrosis (Cirrhosis) 05/2020
1	Dyslipidemias (Dyslipidemia) 05/2020
1	Common Variable Immunodeficiency 01/2020
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2020
1	Type 1 Hyper-IgM Immunodeficiency Syndrome 01/2020
1	Hypersensitivity (Allergy) 01/2020

6	alpha-Mannosidase (LAMAN)IBA 06/2020 - 09/2014
2	Immunoglobulin G (IgG)IBA 01/2020 - 01/2020
1	InterferonsIBA 05/2024
1	HLA Antigens (Human Leukocyte Antigens)IBA 06/2022
1	CalciumIBA 09/2021
1	Calcium-Sensing ReceptorsIBA 09/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021
1	venetoclaxIBA 12/2020
1	Alemtuzumab (Campath)FDA Link 12/2020
1	CatecholaminesIBA 08/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2020
1	CD40 Ligand (CD40L)IBA 01/2020
1	Immunoglobulin A (IgA)IBA 01/2020
1	EnzymesIBA 01/2018